Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy
2018 · Journal of Nanobiotechnology · 50 citations
https://doi.org/10.1186/s12951-018-0431-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
57
Citations
2
h-index
1
i10-index
Lexing Xu is an academic researcher from Zhejiang Pharmaceutical College. The author has contributed to research in topics: Alzheimer's disease research and treatments & Computational Drug Discovery Methods & Respiratory Support and Mechanisms. The author has an h-index of 2, co-authored 2 publications.
Click to start Chat